Company Profiles

Print


IBSA Institut Biochimique SA
Via del Piano, P.O. Box 266,
6915 Pambio-Noranco, Lugano, Switzerland
Company Tel: +41 58 360 10 00
Company Fax: +41 58 360 16 47
General Email Address: info@ibsa.ch
Website: http://www.ibsa-international.com/
IBSA is an international pharmaceutical company headquartered in Lugano, Switzerland, delivering different therapeutic solutions for follicular stimulation and luteal support.
IBSA developed an entirely new purification process to obtain a full range of highly purified, human gonadotrophins: hFSH, hMG and hCG.
This unique patented process was conceived to ensure at the same time both high purity and the respect of the structure–correlate activities of the gonadotrophins (natural glycosylation).
IBSA's whole in-house manufacturing ensures the same global quality system in company owned plants, from the first steps of raw materials to the final lyophilized products.
Other company's franchises include osteoarthritis, pain-management, dermatology and thyroid diseases.

Ariosa Diagnostics, Inc. is a leading global molecular diagnostics company committed to improving overall patient care by developing and delivering innovative, affordable, and widely-accessible testing services through their CLIA laboratory. Tests are fully validated to CLIA requirements by rigorous and comprehensive methodologies to ensure health care practitioners and patients can be confident in the test's performance. Ariosa has developed leading-edge technologies to perform a directed analysis of cell-free DNA in blood. Ariosa is located in San Jose, California and was acquired by Roche in 2015.



Gene by Gene, Ltd.
1445 North Loop West, Suite 820
Houston, TX 77008
Phone: +1.713.474.2401
Fax: +1.713.230.8999
Email: info@genebygene.com
www.genebygene.com
Gene by Gene (www.genebygene.com), is located in Houston, Texas, where it has a state-of-the-art, fully-automated, CAP and CLIA certified high throughput commercial laboratory, capable of massive genotyping, data handling and interpretation. The company's goal is to have a pivotal role in a multidisciplinary effort for Applied and Translational Genomics collaborating with leading research groups. Ultimately, Gene by Gene's interest is in developing robust, reliable, accurate and low-priced genetic testing to the general public so that responsible personalized genetic medicine can be affordable and within reach to any individual worldwide.


Sequenom Laboratories (headquarters)
3595 John Hopkins Ct.
San Diego, CA 92121
United States
Phone: +1.858.202.9000
Fax: +1.858.202.9205
Email:
info@sequenom.com
URL:http://www.laboratories.sequenom.com/
Sequenom Laboratories first introduced noninvasive prenatal testing (NIPT) with the MaterniT21® PLUS laboratory-developed test, which supplies comprehensive information on the chromosomal health of the fetus. We are pleased to now offer the VisibiliT™ laboratory-developed test, which is designed to mirror serum screening, offering standard chromosomal information about the fetus. Through a routine blood draw, both tests can be administered as early as 10 weeks' gestation—without the risks associated with invasive prenatal testing procedures.




Phone: (888) 268-6795
General email: support@counsyl.com
Counsyl is a technology-driven medical laboratory that offers clinically comprehensive, affordable, and high quality genetic screening and complimentary genetic counseling. The Counsyl Family Prep Screen, as prescribed by a physician, provides vital information to help people plan for growing families. This expanded carrier screen can detect over 100 inherited health conditions such as cystic fibrosis, spinal muscular atrophy and fragile X. Counsyl is based in San Francisco, California, USA. Since 2009, we have screened 350,000+ patients.

Cartagenia delivers diagnostic support software, systems and services to enable genetic labs, pathology labs and clinicians to perform clinically relevant genetic analyses quickly and efficiently, allowing them to offer patients and carers high quality genetic interpretation and counseling. For more information, visit www.cartagenia.com

Genesis Genetics
London BioScience Innovation Centre (Kings Cross)
2 Royal College Street
London NW1 0NH UK
www.GenesisGenetics.co.uk
 

Natera is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA. The mission of the company is to help families diagnose and manage genetic disease. Towards that mission, Natera operates a CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA), currently offering a host of preconception and prenatal genetic screening and testing services primarily to OBGYN physicians and in-vitro fertilization centers. These tests include Panorama™, non-invasive prenatal test that identifies most common chromosomal anomalies. Natera also offers genetic carrier screening, preimplantation genetic diagnosis (PGD), miscarriage testing and paternity testing.



Phone: +44 (0)161 667 6865
Email:
iona@premaitha.com
URL: http://www.premaitha.com/

Premaitha Health is an innovative UK molecular diagnostics company with a non-invasive prenatal screening (NIPT) - the IONA® test. The IONA® test is a quality assured (CE-marked) kit that enables local clinical testing with results available in 3 days. The IONA® test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The IONA® test has a higher detection rate and lower false positive rate than existing screening tests, giving pregnant women, their families and their doctors greater confidence in the result and reducing the need for unnecessary invasive follow-up tests and the associated anxiety and stress.

 

PerkinElmer is a global company focused on improving the health and safety of people and their environment.
The company supplies instruments, test kits and risk calculation software to screen for pregnancy abnormalities.
As a pioneer in methods for prediction of pre-eclampsia, PerkinElmer offers a growing portfolio of innovative products based on the PlGF serum marker.
PlGF also has value as a Down syndrome marker. Various other 1st and 2nd trimester aneuploidy markers are reliably detected by PerkinElmer serum or dried blood spot screening assays. In addition, the Prenatal BoBs™ product allows molecular karyotyping.
Company name: PerkinElmer
Stand no:
Address: Mustionkatu 6, 20750 Turku, Finland
Telno: +358-2-2678 111
Website:www.perkinelmer.com/MaternalFetalHealth
Contact name: Yvonne Parker
Email: yvonne.parker@perkinelmer.com